Cushing's disease significantly impacts anterior pituitary function, affecting growth hormone (GH) and prolactin (PRL) secretion. This study reveals multiple pituitary hormone abnormalities in patients with this condition.
Area of Science:
Endocrinology
Neuroendocrinology
Pituitary Gland Physiology
Background:
Cushing's disease is a complex endocrine disorder characterized by excessive cortisol production.
The hypothalamic-pituitary axis is crucial for regulating hormone secretion, and its dysfunction can lead to various clinical manifestations.
Understanding the extent of pituitary involvement in Cushing's disease is essential for comprehensive patient management.
Purpose of the Study:
To comprehensively evaluate hypothalamic-pituitary function in patients diagnosed with Cushing's disease.
To identify specific anterior pituitary hormone secretion abnormalities associated with Cushing's disease.
To correlate pituitary dysfunction with the underlying pathology of Cushing's disease.
Main Methods:
Assessment of hypothalamic-pituitary function in seven patients with confirmed Cushing's disease.
Stimulation tests were performed, including insulin hypoglycemia, TRH stimulation, chlorpromazine administration, and LHRH administration.
Basal and stimulated levels of Growth Hormone (GH), Prolactin (PRL), Thyroid-Stimulating Hormone (TSH), Luteinizing Hormone (LH), and Follicle-Stimulating Hormone (FSH) were measured.
Main Results:
Absence of GH elevation following hypoglycemia was observed in all seven patients.
Abnormalities in PRL secretion included basal hyperprolactinemia in three patients and blunted responses to insulin hypoglycemia and chlorpromazine in four and six patients, respectively.
Impaired TSH response to TRH occurred in five patients, and low basal LH/FSH levels with attenuated or absent responses to LHRH were noted in multiple subjects.
Conclusions:
Cushing's disease is associated with widespread anterior pituitary hormone secretion abnormalities.
The observed pituitary dysfunctions, including GH, PRL, TSH, and gonadotropin deficiencies, highlight the systemic impact of the disease.
These findings underscore the necessity of thorough pituitary evaluation in the management of Cushing's disease.